GOCO - GoHealth Q2 GAAP EPS misses revenue beats FY22 guidance suspended
- GoHealth press release ( NASDAQ: GOCO ): Q2 GAAP EPS of -$0.35 (-$0.12 Y/Y) misses by $0.12 .
- Revenue of $158.7M (-19.4% Y/Y) beats by $24.8M .
- "We have made the prudent decision to suspend the Company's previously issued quantitative guidance for the remainder of 2022," CEO Vijay Kotte said.
For further details see:
GoHealth Q2 GAAP EPS misses, revenue beats, FY22 guidance suspended